Extensive red blood cell matching considering patient alloimmunization risk

Abstract Background and Objectives Red blood cell (RBC) transfusions pose a risk of alloantibody development in patients. For patients with increased alloimmunization risk, extended preventive matching is advised, encompassing not only the ABO‐D blood groups but also the most clinically relevant minor antigens: C, c, E, e, K, Fy a , Fy b , Jk a , Jk b , S and s. This study incorporates patient‐specific data and the clinical consequences of mismatching into the allocation process. Materials and Methods We have redefined the MINimize Relative Alloimmunization Risks (MINRAR) model to include patient group preferences in selecting RBC units from a finite supply. A linear optimization approach was employed, considering both antigen immunogenicity and the clinical impact of mismatches for specific patient groups. We also explore the advantages of informing the blood bank about scheduled transfusions, allowing for a more strategic blood distribution. The model is evaluated using historical data from two Dutch hospitals, measuring shortages and minor antigen mismatches. Results The updated model, emphasizing patient group‐specific considerations, achieves a similar number of mismatches as the original, yet shifts mismatches among patient groups and antigens, reducing expected alloimmunization consequences. Simultaneous matching for multiple hospitals at the distribution centre level, considering scheduled demands, led to a 30% decrease in mismatches and a 92% reduction in shortages. Conclusion The reduction of expected alloimmunization consequences by incorporating patient group preferences demonstrates our strategy's effectiveness for patient health. Substantial reductions in mismatches and shortages with multi‐hospital collaboration highlights the importance of sharing information in the blood supply chain.